Vivo Capital’s Zogenix, Inc. ZGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-105,000
| Closed | -$1.71M | – | 57 |
|
|
2021
Q4 | $1.71M | Hold |
105,000
| – | – | 0.1% | 52 |
|
|
2021
Q3 | $1.59M | Hold |
105,000
| – | – | 0.07% | 58 |
|
|
2021
Q2 | $1.81M | Hold |
105,000
| – | – | 0.08% | 56 |
|
|
2021
Q1 | $2.05M | Sell |
105,000
-901,494
| -90% | -$18.5M | 0.07% | 58 |
|
|
2020
Q4 | $20.1M | Buy |
1,006,494
+188,559
| +23% | +$3.85M | 0.9% | 26 |
|
|
2020
Q3 | $14.7M | Buy |
817,935
+159,412
| +24% | +$3.91M | 0.85% | 34 |
|
|
2020
Q2 | $17.8M | Sell |
658,523
-230,201
| -26% | -$6.35M | 1.28% | 21 |
|
|
2020
Q1 | $22M | Buy |
+888,724
| New | +$32.4M | 1.99% | 12 |
|
|
2019
Q3 | – | Sell |
-105,000
| Closed | -$5.02M | – | 50 |
|
|
2019
Q2 | $5.02M | Hold |
105,000
| – | – | 0.47% | 36 |
|
|
2019
Q1 | $5.78M | Hold |
105,000
| – | – | 0.58% | 36 |
|
|
2018
Q4 | $3.83M | Hold |
105,000
| – | – | 0.49% | 32 |
|
|
2018
Q3 | $5.21M | Hold |
105,000
| – | – | 0.52% | 32 |
|
|
2018
Q2 | $4.64M | Hold |
105,000
| – | – | 0.6% | 30 |
|
|
2018
Q1 | $4.21M | Hold |
105,000
| – | – | 0.6% | 26 |
|
|
2017
Q4 | $4.21M | Buy |
+105,000
| New | +$4.03M | 0.9% | 22 |
|
Vivo Capital's ZGNX Position: Q1 2022 in Review
Vivo Capital sold out of Zogenix, Inc. (ZGNX) in Q1 2022, closing a stake of 105,000 shares — an estimated $1.71M sold.
Vivo Capital first reported a position in ZGNX in Q4 2017 and held it in 15 quarters. The position peaked at $22M in Q1 2020. 0 funds tracked by Wall St. Rank hold ZGNX as of Q1 2022.
- Vivo Capital reported no remaining Zogenix, Inc. position as of Q1 2022 after selling out during the quarter.
- Vivo Capital sold 105,000 Zogenix, Inc. shares in Q1 2022, an estimated $1.71M.
- Vivo Capital first reported a position in Zogenix, Inc. in Q4 2017 and held it in 15 quarters.
- Vivo Capital's Zogenix, Inc. position peaked at $22M in Q1 2020.
- 0 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q1 2022.
Based on Vivo Capital's 13F filing for Q1 2022, filed 13 May 2022.